FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagehl7.fhir.uv.ebm
Resource TypeEvidenceVariable
IdEvidenceVariable-7753.json
FHIR VersionR6

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source

Generated Narrative: EvidenceVariable 7753

version: 6; Last updated: 2023-12-01 16:35:08+0000

ArtifactPublicationStatus: Active

url: EvidenceVariable Organ support-free days

identifier: FEvIR Object Identifier/7753, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.52

version: 1.0.0-ballot3

name: Organ_support_free_days

title: Organ support-free days

status: Active

date: 2022-03-07 00:50:50+0000

author: Brian S. Alper:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

The primary outcome was organ support–free days, evaluated on an ordinal scale that combined in-hospital death and the number of days free of cardiovascular or respiratory organ support up to day 21 among patients who survived to hospital discharge. Patients who were discharged from the hospital before day 21 were assumed to be alive and free of organ support through day 21. Any death during the index hospitalization through 90 days was assigned the worst score on the outcome scale (–1). This end point reflects both the use of ICU-level interventions and survival, with higher values indicating better outcomes.

note: ,

Organ support was defined as oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes.

The methods for one of the included trials stated 'Organ Support is defined as receipt of invasive or non-invasive mechanical ventilation, high flow nasal oxygen, vasopressor therapy, or ECMO support'

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

handling: ordinal variable


Source1

{
  "resourceType": "EvidenceVariable",
  "id": "7753",
  "meta": {
    "versionId": "6",
    "lastUpdated": "2023-12-01T16:35:08.324Z"
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type",
            "code": "active",
            "display": "Active"
          }
        ]
      }
    }
  ],
  "url": "https://fevir.net/resources/EvidenceVariable/7753",
  "identifier": [
    {
      "type": {
        "coding": [
          {
            "system": "http://terminology.hl7.org/CodeSystem/v2-0203",
            "code": "ACSN",
            "display": "Accession ID"
          }
        ],
        "text": "FEvIR Object Identifier"
      },
      "system": "https://fevir.net/FOI",
      "value": "7753",
      "assigner": {
        "display": "Computable Publishing LLC"
      }
    },
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.4.642.40.44.24.52"
    }
  ],
  "version": "1.0.0-ballot3",
  "name": "Organ_support_free_days",
  "title": "Organ support-free days",
  "status": "active",
  "date": "2022-03-07T00:50:50.578Z",
  "author": [
    {
      "name": "Brian S. Alper"
    }
  ],
  "publisher": "HL7 International / Clinical Decision Support",
  "contact": [
    {
      "name": "HL7 International / Clinical Decision Support",
      "telecom": [
        {
          "system": "url",
          "value": "http://www.hl7.org/Special/committees/dss"
        }
      ]
    }
  ],
  "description": "The primary outcome was organ support–free days, evaluated on an ordinal scale that combined in-hospital death and the number of days free of cardiovascular or respiratory organ support up to day 21 among patients who survived to hospital discharge. Patients who were discharged from the hospital before day 21 were assumed to be alive and free of organ support through day 21. Any death during the index hospitalization through 90 days was assigned the worst score on the outcome scale (–1). This end point reflects both the use of ICU-level interventions and survival, with higher values indicating better outcomes.",
  "note": [
    {
      "text": "Organ support was defined as oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes."
    },
    {
      "text": "The methods for one of the included trials stated 'Organ Support is defined as receipt of invasive or non-invasive mechanical ventilation, high flow nasal oxygen, vasopressor therapy, or ECMO support'"
    }
  ],
  "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/",
  "handling": "ordinal"
}